Emergency Biosafety Management Practice in Laboratory of Shelter Hospital #MMPMID32980900
Liu YS; Peng DL; Yang J; Chen DY; Jia HB; Yu SY; Chen HH; Chen K; Liu LR
Curr Med Sci 2020[Oct]; 40 (5): 985-988 PMID32980900show ga
At the end of 2019, the novel coronavirus infection outbroke in Wuhan, Hubei Province. On Feb. 2, 2020, Wuhan, as the worst-hit region, began to build "shelter hospital" rapidly to treat patients with mild illness. The shelter hospital has multiple functions such as emergency treatment, surgical treatment and clinical test, which can adapt to emergency medical rescue tasks. Based on the characteristics that shelter hospital only treats patients with mild illness, tests of shelter laboratory, including coronavirus nucleic acid detection, IgM/IgG antibody serology detection, monitoring and auxiliary diagnosis and/or a required blood routine, urine routine, C-reactive protein, calcitonin original, biochemical indicators (liver enzymes, myocardial enzymes, renal function, etc.) and blood coagulation function test etc, were used to provide important basis for the diagnosis and treatment of the disease. In order to ensure laboratory biosafety, it is necessary to first evaluate the harm level of various specimens. In the laboratory biosafety management, the harm level assessment of microorganisms is the core work of biosafety, which is of great significance to guarantee biosafety. As an emergency deployment affected by the environment, shelter laboratory must possess strong mobility. This paper will explore how to combine the biosafety model of traditional laboratory with the particularity of shelter laboratory to carry out effective work in response to the current epidemic.
|Betacoronavirus/*pathogenicity[MESH]
|COVID-19[MESH]
|China[MESH]
|Containment of Biohazards/instrumentation/*methods[MESH]
free
free
free
Curr+Med+Sci 2020 ; 40 (5): 985-988
